Proteomic Discovery of Serum Biomarkers Predictive of Preterm Birth
March 2014 – Dr. Jay Boniface presented the strategy and methodology used for the discovery of proteins predictive of preterm birth risk at the 2014 Society for Gynecologic Investigation’s 61st Annual...
View ArticleDiscovery Assay Development of Biomarkers Predictive of Preterm Birth
June 2014 – Sera Prognostics, Inc. presented the development and analytical performance of a highly multiplexed and targeted mass spectrometry-based assay for biomarker discovery and subsequent...
View ArticleImmunoassay Confirmation of MRM-MS Data Supports a Role for Acute Phase...
March 2015 – Sera Prognostics, Inc. presented data demonstrating correlation between ELISA and MRM-MS at the Society of Reproductive Investigation 2015 Annual Meeting. The acute phase response (APR)...
View ArticleDevelopment and validation of a spontaneous preterm delivery predictor in...
February 2016 – PAPR investigators presented the findings of the landmark PAPR study at the 2016 Society of Maternal-Fetal Medicine meeting. The conclusions of the study and resulting American Journal...
View ArticleImmunoassay Performance of a Preterm Birth Classifier
March 2016 – Sera Prognostics, Inc. presented data demonstrating correlation between ELISA and MRM-MS at the Society of Reproductive Investigation 2016 Annual Meeting. The results of the data...
View ArticlePredicting sPTB: What do we do now?
May 2016 – Published in Contemporary OB/GYN, this supplement captured proceedings of a panel discussion hosted by Sera Prognostics at the 2016 Society of Maternal-Fetal Medicine Annual meeting. Today,...
View ArticleDevelopment and validation of a spontaneous preterm delivery predictor in...
May 2016 This study, published as an Editor’s Choice article in the May issue of American Journal of Obstetrics & Gynecology, concluded that a serum-based molecular predictor (the PreTRM test)...
View ArticlePreterm Birth: can we do better?
October 2016 – Published in the peer-reviewed journal, Proceedings in Obstetrics and Gynecology, the authors present a clinical treatment protocol for testing women early in pregnancy with a validated...
View ArticleCLINICAL AND COST IMPACT ANALYSIS OF A NOVEL PROGNOSTIC TEST FOR EARLY...
December 2016 – Published in the American Journal of Perinatology Reports, the authors of this article concluded that “the use of a prognostic test for reducing spontaneous preterm birth is a dominant...
View ArticleAnalytical Validation of Protein Biomarkers for Risk of Spontaneous Preterm...
June 2017 – Sera’s recent analytical study, “Analytical Validation of Protein Biomarkers for Risk of Spontaneous Preterm Birth” has been published in the June issue of Clinical Mass Spectrometry. The...
View ArticleEffects of Selective Exclusion of Patients on Preterm Birth Test Performance
December 2019 – Published in the peer-reviewed journal, Obstetrics & Gynecology, the authors explain the importance of following best practices for development of omics tests, as formatted into...
View ArticleEnhanced preterm delivery predictors: verification in a large independent...
January 2020 – Abstract of data to evaluate the predictive performance of established preterm birth biomarkers when combined with additional clinical and proteomic markers that will be presented at...
View ArticlePerformance of a proteomic preterm delivery predictor in a large independent...
January 2020 – Abstract of data to determine the performance of a previously validated, clinically available, proteomic preterm birth (PTB) predictor in an independent cohort distinct from the tone in...
View ArticlePublication Demonstrates Ability of Sera Prognostics’ PreTRM® Biomarker Test...
Publication Demonstrates Ability of Sera Prognostics’ PreTRM® Biomarker Test as a Predictor of Adverse Pregnancy Outcomes May 20, 2020 – SALT LAKE CITY — Sera Prognostics, Inc., The Pregnancy Company®...
View Article